Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Symptom-based stratification algorithm for heterogeneous symptoms of dry eye disease: a feasibility study

Abstract

Background/objective

To test the feasibility of a dry eye disease (DED) symptom stratification algorithm previously established for the general population among patients visiting ophthalmologists.

Subject/methods

This retrospective cross-sectional study was conducted between December 2015 and October 2021 at a university hospital in Japan; participants who underwent a comprehensive DED examination and completed the Japanese version of the Ocular Surface Disease Index (J-OSDI) were included. Patients diagnosed with DED were stratified into seven clusters using a previously established symptom-based stratification algorithm for DED. Characteristics of the patients in stratified clusters were compared.

Results

In total, 426 participants were included (median age [interquartile range]; 63 [48–72] years; 357 (83.8%) women). Among them, 291 (68.3%) participants were diagnosed with DED and successfully stratified into seven clusters. The J-OSDI total score was highest in cluster 1 (61.4 [52.2–75.0]), followed by cluster 5 (44.1 [38.8–47.9]). The tear film breakup time was the shortest in cluster 1 (1.5 [1.1–2.1]), followed by cluster 3 (1.6 [1.0–2.5]). The J-OSDI total scores from the stratified clusters in this study and those from the clusters identified in the previous study showed a significant correlation (r = 0.991, P < 0.001).

Conclusions

The patients with DED who visited ophthalmologists were successfully stratified by the previously established algorithm for the general population, uncovering patterns for their seemingly heterogeneous and variable clinical characteristics of DED. The results have important implications for promoting treatment interventions tailored to individual patients and implementing smartphone-based clinical data collection in the future.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Hierarchical heat map of dry eye disease subjective symptoms determined by the Japanese version of the Ocular Surface Disease Index score (J-OSDI).
Fig. 2: Heatmap of severity ranks of dry eye disease examination by clusters.
Fig. 3: Comparison of the Japanese version of the Ocular Surface Disease Index score (J-OSDI) between patients in this study and smartphone application users in a previous study by each stratified cluster.

Similar content being viewed by others

Data availability

All data are available in the main text. The code supporting the findings of this study is available from the corresponding author upon reasonable request. Data processing and analysis were performed using STATA version 16.1.

References

  1. Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15:276–83.

    Article  PubMed  Google Scholar 

  2. Tsubota K, Yokoi N, Shimazaki J, Watanabe H, Dogru M, Yamada M, et al. New perspectives on Dry eye definition and diagnosis: a consensus report by the asia dry eye society. Ocul Surf. 2017;15:65–76.

    Article  PubMed  Google Scholar 

  3. Kaido M, Ishida R, Dogru M, Tsubota K. The relation of functional visual acuity measurement methodology to tear functions and ocular surface status. Jpn. J Ophthalmol. 2011;55:451–9.

    Article  PubMed  Google Scholar 

  4. Belmonte C, Nichols JJ, Cox SM, Brock JA, Begley CG, Bereiter DA, et al. TFOS DEWS II pain and sensation report. Ocul Surf. 2017;15:404–37.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Yamada M, Mizuno Y, Shigeyasu C. Impact of dry eye on work productivity. Clinicoecon Outcomes Res. 2012;4:307–12.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Jones L, Downie LE, Korb D, Benitez-Del-Castillo JM, Dana R, Deng SX, et al. TFOS DEWS II management and therapy report. Ocul Surf. 2017;15:575–628.

    Article  PubMed  Google Scholar 

  7. Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, et al. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15:334–65.

    Article  PubMed  Google Scholar 

  8. Inomata T, Shiang T, Iwagami M, Sakemi F, Fujimoto K, Okumura Y, et al. Changes in distribution of dry eye disease by the new 2016 diagnostic criteria from the asia dry eye society. Sci Rep. 2018;8:1918.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Inomata T, Nakamura M, Iwagami M, Shiang T, Yoshimura Y, Fujimoto K, et al. Risk factors for severe dry eye disease: crowdsourced research using DryEyeRhythm. Ophthalmology. 2019;126:766–8.

    Article  PubMed  Google Scholar 

  10. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 2000;118:615–21.

    Article  CAS  PubMed  Google Scholar 

  11. Midorikawa-Inomata A, Inomata T, Nojiri S, Nakamura M, Iwagami M, Fujimoto K, et al. Reliability and validity of the Japanese version of the ocular surface disease index for dry eye disease. BMJ Open. 2019;9:e033940.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Okumura Y, Inomata T, Iwata N, Sung J, Fujimoto K, Fujio K, et al. A review of dry eye questionnaires: measuring patient-reported outcomes and health-related quality of life. Diagnostics (Basel). 2020;10:559.

    Article  PubMed  Google Scholar 

  13. Tan G, Li J, Yang Q, Wu A, Qu DY, Wang Y, et al. Air pollutant particulate matter 2.5 induces dry eye syndrome in mice. Sci Rep. 2018;8:17828.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Inomata T, Iwagami M, Nakamura M, Shiang T, Yoshimura Y, Fujimoto K, et al. Characteristics and risk factors associated with diagnosed and undiagnosed symptomatic dry eye using a smartphone application. JAMA Ophthalmol. 2020;138:58–68.

    Article  PubMed  Google Scholar 

  15. Inomata T, Sung J, Nakamura M, Iwagami M, Okumura Y, Iwata N, et al. Using medical big data to develop personalized medicine for dry eye disease. Cornea. 2020;39:S39–S46.

    Article  PubMed  Google Scholar 

  16. Bradway M, Carrion C, Vallespin B, Saadatfard O, Puigdomènech E, Espallargues M, et al. mHealth assessment: conceptualization of a global framework. JMIR Mhealth Uhealth. 2017;5:e60.

    Article  PubMed  Google Scholar 

  17. World Health Organization. mHealth: new horizons for health through mobile technologies: second global survey on eHealth. Available at: https://www.who.int/goe/publications/goe_mhealth_web.pdf. Accessed December 6, 2019.

  18. Onnela JP, Rauch SL. Harnessing smartphone-based digital phenotyping to enhance behavioral and mental health. Neuropsychopharmacology. 2016;41:1691–6.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Jain SH, Powers BW, Hawkins JB, Brownstein JS. The digital phenotype. Nat Biotechnol. 2015;33:462–3.

    Article  CAS  PubMed  Google Scholar 

  20. Bottomley A, Jones D, Claassens L. Patient-reported outcomes: assessment and current perspectives of the guidelines of the food and drug administration and the reflection paper of the European medicines agency. Eur J Cancer. 2009;45:347–53.

    Article  PubMed  Google Scholar 

  21. Weldring T, Smith SM. Patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs). Health Serv Insights. 2013;6:61–68.

    PubMed  PubMed Central  Google Scholar 

  22. Inomata T, Nakamura M, Iwagami M, Midorikawa-Inomata A, Sung J, Fujimoto K, et al. Stratification of individual symptoms of contact lens-associated dry eye using the iPhone app DryEyeRhythm: crowdsourced cross-sectional study. J Med Internet Res. 2020;22:e18996.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Inomata T, Iwagami M, Nakamura M, Shiang T, Fujimoto K, Okumura Y, et al. Association between dry eye and depressive symptoms: Large-scale crowdsourced research using the DryEyeRhythm iPhone application. Ocul Surf. 2020;18:312–9.

    Article  PubMed  Google Scholar 

  24. Inomata T, Nakamura M, Sung J, Midorikawa-Inomata A, Iwagami M, Fujio K, et al. Smartphone-based digital phenotyping for dry eye toward P4 medicine: a crowdsourced cross-sectional study. NPJ Digit Med. 2021;4:171.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Inomata T, Sung J, Nakamura M, Fujisawa K, Muto K, Ebihara N, et al. New medical big data for P4 medicine on allergic conjunctivitis. Allergol Int. 2020;69:510–8.

    Article  CAS  PubMed  Google Scholar 

  26. Hood L, Friend SH. Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat Rev Clin Oncol. 2011;8:184–7.

    Article  PubMed  Google Scholar 

  27. Hirosawa K, Inomata T, Sung J, Nakamura M, Okumura Y, Midorikawa-Inomata A, et al. Diagnostic ability of maximum blink interval together with Japanese version of ocular surface disease index score for dry eye disease. Sci Rep. 2020;10:18106.

  28. van Bijsterveld OP. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol. 1969;82:10–14.

    Article  PubMed  Google Scholar 

  29. Inomata T, Iwagami M, Hiratsuka Y, Fujimoto K, Okumura Y, Shiang T, et al. Maximum blink interval is associated with tear film breakup time: a new simple, screening test for dry eye disease. Sci Rep. 2018;8:13443.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Healthcare Engineering Association of Japan Standard Working Group. The guideline for design and operation of hospital HVAC systems: healthcare engineering association of Japan. 2013.

  31. von Luxburg U. A tutorial on spectral clustering. Stat Comput. 2007;17:395–416.

    Article  Google Scholar 

  32. McInnes L, Healy J. UMAP uniform manifold approximation and projection for dimension reduction. ArXiv 2018; https://doi.org/10.48550/arXiv.1802.03426

  33. Tsubota K, Yokoi N, Watanabe H, Dogru M, Kojima T, Yamada M, et al. A new perspective on dry eye classification: proposal by the asia dry eye society. Eye Contact Lens. 2020;46:S2–s13.

    Article  PubMed  Google Scholar 

  34. Vehof J, Sillevis Smitt-Kamminga N, Nibourg SA, Hammond CJ. Predictors of discordance between symptoms and signs in dry eye disease. Ophthalmology. 2017;124:280–6.

    Article  PubMed  Google Scholar 

  35. Galor A, Zlotcavitch L, Walter SD, Felix ER, Feuer W, Martin ER, et al. Dry eye symptom severity and persistence are associated with symptoms of neuropathic pain. Br J Ophthalmol. 2015;99:665–8.

    Article  Google Scholar 

  36. Woolf CJ, Safieh-Garabedian B, Ma QP, Crilly P, Winter J. Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience. 1994;62:327–31.

    Article  CAS  PubMed  Google Scholar 

  37. Benitez-Del-Castillo JM, Acosta MC, Wassfi MA, Diaz-Valle D, Gegundez JA, Fernandez C, et al. Relation between corneal innervation with confocal microscopy and corneal sensitivity with noncontact esthesiometry in patients with dry eye. Invest Ophthalmol Vis Sci. 2007;48:173–81.

    Article  PubMed  Google Scholar 

  38. Yokoi N, Uchino M, Uchino Y, Dogru M, Kawashima M, Komuro A, et al. Importance of tear film instability in dry eye disease in office workers using visual display terminals: the Osaka study. Am J Ophthalmol. 2015;159:748–54.

    Article  PubMed  Google Scholar 

  39. Tagawa Y, Noda K, Ohguchi T, Tagawa Y, Ishida S, Kitaichi N. Corneal hyperalgesia in patients with short tear film break-up time dry eye. Ocul Surf. 2019;17:55–59.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank OHAKO, Inc. (Tokyo, Japan) and Medical Logue, Inc. (Tokyo, Japan) for developing the DryEyeRhythm application, and Shiang T, Yoshimura Y, Hirastuka Y, Hori S, Uchino M, and Tsubota K for the initial development of the application.

Funding

This research was supported by JST COI Grant Number JPMJCER02WD02 (TI), JSPS KAKENHI Grant Numbers 20KK0207 (TI), 20K23168 (AMI), 21K17311 (AMI), 21K20998 (AE), and 22K16983 (AE), Kondou Kinen Medical Foundation, Medical Research Encouragement Prize 2020 (TI), Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical’s Founder 2020 (TI), Nishikawa Medical Foundation, Medical Research Encouragement Prize 2020 (TI), and the OTC Self- Medication Promotion Foundation (YO). The sponsors had no role in the design or performance of the study, in data collection and management, in the analysis and interpretation of the data, in the preparation, review, approval of the manuscript, or in the decision to submit the manuscript for publication.

Author information

Authors and Affiliations

Authors

Contributions

KN was responsible for methodology, data curation, software, visualization, formal analysis, investigation, writing-original draft preparation, and writing-reviewing and editing. TI was responsible for conceptualization, methodology, validation, investigation, writing-original draft preparation, and writing-reviewing and editing. MN was responsible for software, visualization, formal analysis, investigation, and writing-reviewing and editing. JS conducted the investigation and wrote the original draft, and reviewed and edited the manuscript. AMI performed validation, investigation, writing-original draft preparation, and writing-reviewing and editing. MI performed validation, investigation, writing-original draft preparation, and writing-reviewing and editing. KF performed data curation, validation, investigation, writing-original draft preparation, and writing reviewing and editing. YA performed data curation, validation, investigation, writing-original draft preparation, and writing-reviewing and editing. YO performed data curation, validation, investigation, writing-original draft preparation, and writing-reviewing and editing. TH performed data curation, validation, investigation, writing-original draft preparation, and writing-reviewing and editing. KF performed validation, investigation, writing-original draft preparation, and writing-reviewing and editing. AE performed validation, investigation, writing-original draft preparation, and writing-reviewing and editing. MM performed data curation, investigation, writing-original draft preparation, and writing-reviewing and editing. SH performed validation, investigation, writing-original draft preparation, and writing-reviewing and editing. JZ performed validation, investigation, writing-original draft preparation, and writing-reviewing and editing. MK performed validation, investigation, writing-original draft preparation, and writing-reviewing and editing. KH performed validation, investigation, writing-original draft preparation, and writing-reviewing and editing. YM performed validation, investigation, writing-original draft preparation, and writing-reviewing and editing. RD performed validation, investigation, writing-original draft preparation, and writing-reviewing and editing. AM performed validation, investigation, writing-original draft preparation, and writing-reviewing and editing. HK performed validation, investigation, writing-original draft preparation, and writing-reviewing and editing.

Corresponding author

Correspondence to Takenori Inomata.

Ethics declarations

Competing interests

The DryEyeRhythm app was created using Apple’s ResearchKit (Cupertino, CA, USA) along with OHAKO, Inc. (Tokyo, Japan) and Medical Logue, Inc. (Tokyo, Japan). TI and YO are the owners of InnoJin, Inc, Tokyo, Japan, for developing DryEyeRhythm. TI reported receiving grants from Johnson & Johnson Vision Care, SEED Co., Ltd, Novartis Pharma K.K., and Kowa Company, Ltd. outside the submitted work, as well as personal fees from Santen Pharmaceutical Co., Ltd., and InnoJin, Inc. The remaining authors declare no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nagino, K., Inomata, T., Nakamura, M. et al. Symptom-based stratification algorithm for heterogeneous symptoms of dry eye disease: a feasibility study. Eye 37, 3484–3491 (2023). https://doi.org/10.1038/s41433-023-02538-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41433-023-02538-4

This article is cited by

Search

Quick links